ODYY (Odyssey Health) Short-Term Debt: $2.64 Mil (As of Apr. 2026)


What is Odyssey Health Short-Term Debt?

Odyssey Health ODYY +2.86% Short-Term Debt is $2.64 Mil as of Apr. 2026. The stock has 4 warning signs investors should review.

Odyssey Health's Short-Term Debt for the quarter that ended in Apr. 2026 was $2.64 Mil.

Odyssey Health's quarterly Short-Term Debt increased from Oct. 2025 ($1.97 Mil) to Jan. 2026 ($2.27 Mil) and increased from Jan. 2026 ($2.27 Mil) to Apr. 2026 ($2.64 Mil).

Odyssey Health's annual Short-Term Debt declined from Jul. 2023 ($2.15 Mil) to Jul. 2024 ($1.65 Mil) but then increased from Jul. 2024 ($1.65 Mil) to Jul. 2025 ($1.98 Mil).

Odyssey Health Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Odyssey Health Short-Term Debt Related Terms

Odyssey Health Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Odyssey Health's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Odyssey Health Short-Term Debt Chart

Odyssey Health Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 1.53 2.15 1.65 1.98

Odyssey Health Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.98 1.98 1.97 2.27 2.64
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $2.64 Mil mean?
Odyssey Health (ODYY) has a Short-Term Debt of $2.64 Mil as of Apr. 2026.
Is Odyssey Health's Short-Term Debt too high?
Odyssey Health's current Short-Term Debt is $2.64 Mil.
How does Odyssey Health's Short-Term Debt compare to SSKN and NUMD?
Odyssey Health's Short-Term Debt of $2.64 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Odyssey Health's current Short-Term Debt is $2.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Odyssey Health stock overvalued right now?
Odyssey Health (ODYY) has a current Short-Term Debt of $2.64 Mil. The current Short-Term Debt is $2.64 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Odyssey Health (ODYY), the current Short-Term Debt is $2.64 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Odyssey Health Business Description

Address 2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102
Odyssey Health Inc is a developing medical and pharmaceutical technology that solves unmet clinical needs and has a substantial market opportunity. Its medical devices include CardioMap and Save-A-Life.